Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugs
Genetic analysis of damage-induced intestinal stem cell division in Drosophila
Toll-like receptor interactions and their contribution to airway inflammation
Psychopathology in Children 5 Years Postparental Death
Heparin-Binding Growth Factors in Aging &Alzheimer's
Recently added grants:
Discovery of Enterovirus D68 2A protease inhibitors for antiviral therapy
Biologically Active Cyclic Peptides
MRI Diffusion in Tumors using Oscillating Gradients
Genomics Of Acute Myeloid Leukemia.
Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005125-001
Application #
6994810
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2004
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening, Reg
Sinicrope, Frank / University of Texas MD Anderson Cancer Center
$1,136,114
Comments
Be the first to comment on this grant